MedPath

Study on the effect of alpha glucosidase inhibitors on glycemic variability in patients of type 1 diabetes mellitus

Not Applicable
Completed
Conditions
Health Condition 1: E108- Type 1 diabetes mellitus with unspecified complications
Registration Number
CTRI/2023/01/049038
Lead Sponsor
Institutional
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
39
Inclusion Criteria

Type 1 Diabetes mellitus patients (atleast 6 months duration)

Age : 12-45 years

HbA1c: = 7.5% and =12%

Exclusion Criteria

Pregnant or lactating females

Known Hypersensitivity to AGIs

Diabetic ketoacidosis

Recent acute illness

Renal dysfunction (S. Creatinine =2mg/dl and/or eGFR <25ml/min/1.73m2)

Chronic liver disease

Inflammatory bowel disease/ intestinal obstruction/ Chronic intestinal malabsorptive disorders

Hemoglobinopathies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath